AlphaYouJH
Insider selling
Jason Haas sold $2.1M of Ligand Pharmaceuticals Inc (LGND) stock
Jason Haas, Dir of Ligand Pharmaceuticals Inc (LGND), sold 7,138 shares of LGND stock worth $2.1M, per an SEC Form 4 filed Aug 14, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Aug 12, 2026, 2 days before it was made public.
LGND has moved +1.8% since the trade date, from $293.27 to $298.50 (Sep 22, 2026 close).
- Traded
- Aug 12, 2026
- Disclosed
- Aug 14, 2026
- Filing delay
- 2 days
- Price since
- +1.8%
- Role
- Dir
- Source
- SEC Form 4
More LGND insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.